YARNO WENDY L 4

What Happened Wendy L. Yarno, a non-employee director of Tarsus Pharmaceuticals (TARS), was granted three equity awards on 2026-06-25: an option for 3,837 shares (grant price $0.00) and two restricted stock unit (RSU) awards for 2,417 and 1,209 shares (total RSUs = 3,626). The reported dollar price for each grant is $0.00 because these are compensatory awards, not open-market purchases or sales. Total shares subject to the awards = 7,463.

Key Details

• Transaction date: 2026-06-25; Form 4 filed 2026-06-29 (filed within two business days, timely).
• Reported price: $0.00 for all three entries (award/grant code A; derivative instruments).
• Shares acquired: 3,837 (option), 2,417 RSUs, 1,209 RSUs — total 7,463.
• Shares owned after transaction: Not specified in the provided filing details.
• Relevant footnotes from the filing:
  • F1: 3,837-option is an annual option for non-employee directors; vests in full one year after grant, subject to continuous service.
  • F2: Each RSU represents a contingent right to one share of common stock.
  • F3: 2,417 RSUs vest in full one year after grant, subject to continuous service.
  • F4: 1,209 RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to continuous service.

Context These transactions are compensatory equity awards to a non-employee director, a common form of director compensation. RSUs and options are derivative awards that vest over time and do not represent immediate cash proceeds or open-market buying/selling. The filing appears timely under Form 4 rules (reported within two business days of the transaction).